Diabetron CR

Diabetron CR (Gliclazide Controlled Release Tablets) by FEROZSONS: 30 tablets of 60 mg. It is used to manage type 2 diabetes by helping control high blood sugar levels.

Package Contains: Each Diabetron CR package contains 60mg of 30 tablets & a leaflet. It is also available in 30mg and 90 mg tablets.

Composition: Product Specifications: Ferozsons

Each controlled-release tablet contains:

Gliclazide B.P. 60 mg

Dosage: Use as directed by the physician. (See literature insert for details)

Indications / Uses: Diabetron CR (Gliclazide) is indicated in adults for the treatment of non-insulin-dependent diabetes (type 2) when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.

Dosage & Administration: The daily dose may vary from 30 to 120 mg (i.e. 1 to 4 tablets of 30 mg per day or ½ to 2 tablets of 60 mg per day) taken orally in a single intake at breakfast time.

As with any hypoglycaemic agent, the dose should be adjusted according to the patient’s metabolic response (blood glucose, HbA1c).
Initial dose: The recommended starting dose is 30 mg daily.
If blood glucose is effectively controlled, this dose may be used for maintenance treatment.
If blood glucose is not adequately controlled, the dose may be increased to 60, 90, or 120 mg daily, in successive steps. The interval between each dose increment should be at least one month except in patients whose blood glucose has not reduced after two weeks. In such cases, the dose may be increased at the end of the second week of treatment.
The maximum recommended daily dose is 120 mg.

Adverse Reactions: Based on the experience with gliclazide, the following undesirable effects have been reported.

As for other sulfonylureas, treatment with gliclazide can cause hypoglycaemia, if mealtimes are irregular and, in particular, if meals are skipped. Possible symptoms of hypoglycaemia are headache, Intense hunger, nausea, vomiting, lassitude, sleep disorders, agitation, aggression, poor concentration, reduced awareness and slowed reactions, depression confusion, visual and speech disorders, aphasia, tremor, paresis, sensory disorders, dizziness, feeling of powerlessness, loss of self-control, delirium, convulsions, shallow respiration, bradycardia, drowsiness and lose of consciousness, possibly resulting in coma and lethal outcome In addition, signs of adrenergic counter-regulation may be otiserved sweating, clammy skin, anxiety, tachycardia, hypertension, palpitations, angina pectoris and cardiac arrhythmia Usualty, symptoms disappear after intake of carbohydrates (sugar) However, artificial sweeteners have no effact. Experiance with other sulfonylureas shows that hypoglycaemia can recur even when measures effective initially.

It a hypoglycaemic episode is severe or prolonged, and even if it is temporarily controlled by intake of sugar, immediate medical treatment or even hospitalisation are required.

Pregnancy: There is no or limited amount of data (less than 300 pregnancy outcomes) from the use of gliclazide in pregnant women, even though there are few data with other sulfonylureas.

In animal studies, gliclazide is not teratogenic. As a precautionary measure, avoid the use of Gliclazide during pregnancy. Control of diabetes should ideally be achieved before the time of conception to reduce the risk of congenital abnormalities linked to uncontrolled diabetes.

Oral hypoglycaemic agents are not suitable; insulin is the drug of first choice during pregnancy. It is recommended that oral hypoglycaemic treatment be switched to insulin before pregnancy is attempted, or as soon as pregnancy is discovered.

Lactation: It is unknown whether gliclazide or its metabolites are excreted in human milk. A risk of neonatal hypoglycaemia cannot be excluded. The product is therefore contra-indicated in breast-feeding.

Fertility: No effect on fertility or reproductive performance was noted in male and female rats.

Elderly: Diabetron CR (gliclazide) tablets should be prescribed using the same dosing regimen as in patients under 65 years.

Instructions: Do not store above 30°C.

Keep away from heat, light and moisture.

Keep all medicines out of the reach of children.

To be sold on the prescription of a registered medical practitioner only.

Manufacturer & Buy Online:

Diabetron CR tablets are manufactured by: FEROZSONS LABORATORIES LIMITED.

This is the link to the manufacturer: https://ferozsons-labs

You can buy it online at: https://www.dvago.pk

You can buy it from any nearby pharmacy. It is currently (2026) available at the retail price of around 609 rupees.

By: Urooj